Tag: CORO
Less Than 1 Percent of COVID-19 Patients Experience Recurrence
90 percent of repeat positive tests ≥60 days from initial diagnosis are not consistent with true recurrence
Venous Thromboembolic Event Rates Up With ChAdOx1-S Vaccine
However, absolute risks are small, with 11 excess venous thromboembolic events per 100,000 vaccinations
Hospitalization Rates Overestimate COVID-19 Burden in Children
Almost 40 percent of the SARS-CoV-2-positive pediatric patients with hospitalization were asymptomatic
Infliximab May Reduce Immunogenicity to SARS-CoV-2 Vaccine
Antibody concentrations lower in infliximab-treated individuals with IBD receiving single dose of BNT162b2 or ChAdOx1 nCoV-19 vaccine
After Setbacks, Sanofi/GSK COVID-19 Vaccine Performs Well in Early Trial
Researchers had to go back to the drawing board after early testing produced only a weak immune response in older people
mRNA Vaccines Effective for Preventing Symptomatic COVID-19
Vaccine effectiveness 82 and 94 percent for single dose, two doses among U.S. health care personnel at 33 sites across 25 U.S. states
Ohio Lottery Will Award $1 Million to Five Vaccinated Residents
All Ohio residents who are older than 18 years of age and have received at least one dose of a COVID-19 vaccine are eligible
Most Japanese Want Olympic Games Delayed or Canceled: Poll
The latest COVID-19 wave has put Japan's health care system under pressure
Systemic Reactogenicity Up With Heterologous COVID-19 Vaccine Doses
More reported feverishness, chills, fatigue, headache, joint pain, malaise, muscle ache after heterologous versus homogenous doses
Risk for Severe Effects Low After SARS-CoV-2 Without Hospitalization
Risks for receiving hospital diagnosis of dyspnea, venous thromboembolism slightly increased, but no increased risk seen for other diagnoses
